JAMS

Kimberly Taylor, Esq., Assumes Role as JAMS CEO and President

Ms. Taylor leverages over two decades of leadership experience at JAMS in new role IRVINE, Calif. – JAMS, the largest private provider of alternative dispute resolution (ADR) services worldwide, is pleased to announce that Kimberly Taylor, Esq., has been appointed to the role of CEO and president, effective October 1. Ms. Taylor takes over for Chris Poole, who steps down from the position after leading the organization for … Continue reading Kimberly Taylor, Esq., Assumes Role as JAMS CEO and President

ADOCIA

ADOCIA Announces Appointment of Mathieu‑William Gilbert as Chief Financial Officer

LYON, France–(BUSINESS WIRE)–Regulatory News: “We have had the time for a thorough transition with Mathieu, and I have come to appreciate his skills and strategic vision. Lastly, I would like to thank Gérard and Olivier for trusting me and for the intense and rewarding years we have spent together.” Post this Adocia (Euronext Paris: FR0011184241 – ADOC, the “Company”), a clinical-stage biopharmaceutical company focused on … Continue reading ADOCIA Announces Appointment of Mathieu‑William Gilbert as Chief Financial Officer

KENVUE

Kenvue Drives Climate Action Strategy Forward

SKILLMAN, N.J. – Kenvue Inc. (NYSE: KVUE) (“Kenvue” or the “Company”), the maker of iconic brands such as Aveeno®, Listerine®, Neutrogena® and Tylenol®, is advancing progress toward the climate change goals outlined in its Healthy Lives Mission environmental, social and governance strategy, including releasing its first Task Force on Climate-related Financial Disclosures (TCFD) report. “We have made meaningful progress, including the validation of our near-term … Continue reading Kenvue Drives Climate Action Strategy Forward

Acadia

Catherine Owen Adams Succeeds Steve Davis as CEO of Acadia Pharmaceuticals

– Ms. Owen Adams brings over 25 years of pharmaceutical industry experience including senior commercial leadership roles with Bristol Myers Squibb and Johnson & Johnson SAN DIEGO, Sep. 23, 2024 – Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that Catherine Owen Adams has succeeded Steve Davis as Chief Executive Officer (CEO) and joined the Acadia Board of Directors. “We are excited to welcome Catherine Owen … Continue reading Catherine Owen Adams Succeeds Steve Davis as CEO of Acadia Pharmaceuticals

Accellix

Accellix Appoints Greg Hamilton as Chief Executive Officer as Company Accelerates Growth in Cell Therapy and Blood Bank Markets

SAN JOSE, Calif. & JERUSALEM – Accellix, Inc., the leading sample to answer flow cytometry GMP platform company, is pleased to announce the appointment of Greg Hamilton as Chief Executive Officer and member of the Board effective September 23, 2024. He brings over 25 years of management experience in molecular diagnostics, life science tools, manufacturing and professional service industries as the company ramps growth in … Continue reading Accellix Appoints Greg Hamilton as Chief Executive Officer as Company Accelerates Growth in Cell Therapy and Blood Bank Markets